Keep a close eye on OXX and its options, if MOG/MEO/CUE run on success the market may lag in waking up to OXX's exposure to both CUE/MOG. IMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025